Skip to main content

Advertisement

Log in

Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

There is a broad range of complex ethical issues in the conduct of psychopharmacological drug studies that go beyond the question of the ethics of placebo controls. However, our empirical knowledge with respect to these issues is very limited. This review, although not exhaustive, highlights an array of ethical issues that arose from discussions within the NIMH Human Subjects Research Council Workgroup.

Objectives

To delineate issues in psychopharmacological drug studies that require debate and would benefit from research leading to the development of empirically-supported guidelines.

Methods

Information included in this report was drawn from the first author's participation as chair of the NIMH Human Subjects Research Council Workgroup, guidelines for the ethical conduct of research proposed by professional organizations to which the first and third author belong, and relevant research literature.

Results

We have focused on general issues relating to informed consent, research with special populations, and long-term treatment studies. Additionally, we raise issues relevant to large research-oriented institutions.

Conclusions

The essential ethical challenge in psychopharmacological trials is to balance risks and benefits in the context of the needs and capacities of individual research subjects. The IRB system must become evidence-based and not rely on unproven assumptions. Specific research studies should be undertaken to address many of the issues of informed consent and research ethics postulated in this paper.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Altshuler LL, Hendrick V, Cohen LS (1998) Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 59:29–33

    Google Scholar 

  • Altshuler LL, Cohen LS, Moline ML, Kahn DA, Carpenter D, Docherty JP (2001) Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract 7:185–208

    Google Scholar 

  • American College of Neuropsychopharmacology (2001) A statement of principles of ethical conduct for neuropsychopharmacologic research in human subjects. In: Directory of Members 2001. ACNP, Nashville, pp 225–238

  • American Psychiatric Association (1993) Clinical practice guidelines for MDD in adults. Am J Psychiatry 150:15–16

    Google Scholar 

  • Angst J, Sellaro R (2000) Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 48:445–457

    CAS  PubMed  Google Scholar 

  • Annas GJ (2001) Reforming informed consent to genetic research. JAMA 286:2326-2328

    CAS  PubMed  Google Scholar 

  • Appelbaum PS, Grisso T (1995) The MacArthur treatment competence study I, II, III. Law Hum Behav 19:105–174

    PubMed  Google Scholar 

  • Appelbaum PS, Grisso T, Frank E, O'Donnell S, Kupfer DJ (1999) Competence of depressed patients for consent to research. Am J Psychiatry 156:1380–1384

    CAS  PubMed  Google Scholar 

  • Avins AL (1998) Can unequal be more fair? Ethics, subject allocation, and randomized clinical trials. J Med Ethics 24:401–408

    CAS  PubMed  Google Scholar 

  • Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS (2000) Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 57:533–538

    Article  PubMed  Google Scholar 

  • Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, Siegler M (1995) Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13:1062–1072

    CAS  PubMed  Google Scholar 

  • D'Souza DC, Krystal JH (2001) Psychopharmacological challenge studies in psychiatric research. Int Rev Psychiatry 13:40–46

    Google Scholar 

  • Food and Drug Administration: Department of Health and Human Services (1993) Guidelines for the study and evaluation of gender differences in the clinical evaluation of drugs (Docket No. 93D-0236). Washington, D.C.

  • Foucar E (2001) How much oversight is necessary to protect human subjects? JAMA 287:716–717

    Google Scholar 

  • Fowles ER (1998) The relationship between maternal role attainment and postpartum depression. Health Care for Women International 19:83–94

    CAS  PubMed  Google Scholar 

  • Gaylin W (1982) The competence of children: no longer all or none. Hastings Center Report 12:33–38

    CAS  PubMed  Google Scholar 

  • Grahnke L (1999) UIC head resigns. Chicago Sun Times, November 9

  • Grush LR, Cohen LS (1998) Treatment of depression during pregnancy: balancing the risks. Harv Rev Psychiatry 6:105–109

    CAS  PubMed  Google Scholar 

  • Heath AC, Yonkers KA (2001) Somatic treatments in depression: Concerns during pregnancy and breastfeeding. In: Yonkers K, Little B (eds) Management of psychiatric disorders in pregnancy. Oxford University Press, New York, pp 82–104

  • Kantor JE (1994) Ethical issues in psychiatric research and training. In: Oldham JM, Riba MB (eds) Annual review of psychiatry, vol 13. American Psychiatric Press, Washington D.C., pp 33–342

  • Kaplan S, Brownlee S (1999) Dying for a cure. US News and World Report, October 11

  • Katz J (1997) Human sacrifice and human experimentation: reflections at Nuremberg. Yale Law School Occasional Papers 2:16–17

    Google Scholar 

  • Llewellyn AM, Stowe ZN, Nemeroff CB (1997) Depression during pregnancy and the puerperium. J Clin Psychiatry 58:26–32

    Google Scholar 

  • Masand PD, Gupta S (1999) SSRIs: an update. Harv Rev Psychiatry 7:69-84

    CAS  PubMed  Google Scholar 

  • Misri S, Kostaras D, Kostaras X (2000) The use of SSRIs during pregnancy and lactation: current knowledge. Can J Psychiatry 45:285–287

    CAS  PubMed  Google Scholar 

  • Munir K, Earls F (1992) Ethical principles governing research in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry 31:408-414

    CAS  PubMed  Google Scholar 

  • National Bioethics Advisory Commission (2001) Ethical and policy issues in research involving human participants. Bethesda, Md.

  • National Institute of Health (2002) Bioethics resources on the Web [on-line]. Available: http://www.nih.gov/sigs/bioethics/IRB.html

  • National Research Council (1997) For the record: protecting electronic health information. National Academy of Sciences, Washington, D.C.

    Google Scholar 

  • Office for Human Research Protection (2002) IRB guidebook (on-line). Available: http://ohrp.osophs.dhhs.gov/irb/irb_guidebook.htm

  • Ondrusek N, Abramovitch R, Pencharz P, Koren G (1998) Empirical examination of the ability of children to consent to clinical research. J Med Ethics 24:158–165

    CAS  PubMed  Google Scholar 

  • Paul M, Foreman DM, Kent L (2000) Outpatient clinic attendance: consent from children and young people—ethical aspects and practical considerations. Clin Child Psychol Psychiatry 5:203–211

    Google Scholar 

  • Quitkin FM (1999) Placebos, drug effects, and study design: a clinician's guide. Am J Psychiatry 156:829–836

    CAS  PubMed  Google Scholar 

  • Roberts LW, Warner TD, Brody JL (2000) Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. Am J Psychiatry 157:67–74

    CAS  PubMed  Google Scholar 

  • Roberts LW, Geppert C, Brody JL (2001a) A framework for considering the ethical aspects of psychiatric research protocols. Com Psychiatry 42:351-363

    CAS  Google Scholar 

  • Roberts LW, Lauriello J, Geppert C, Keith SJ (2001b) Placebos and paradoxes in psychiatric research: an ethics perspective. Biol Psychiatry 49:887–893

    Article  CAS  PubMed  Google Scholar 

  • Roberts LW, Warner TD, Brody JL, Roberts B, Lauriello J, Lyketsos C (2003) Research harm assessments and participation decisions of schizophrenia. Am J Psychiatry (in press)

  • Schaefer A (1982) The ethics of the randomized clinical trial. N Engl J Med 307:719–725

    PubMed  Google Scholar 

  • Shalala D (2000) Protecting research subjects—what must be done. N Engl J Med 343:808–810

    CAS  PubMed  Google Scholar 

  • Spiro HM (1986) Mammon and medicine: the rewards of clinical trials. JAMA 255:1174-1175

    CAS  PubMed  Google Scholar 

  • US Congress, Office of Technology Assessment, Mental Disorders and Genetics (1994) Bridging the gap between research and society (publication no. OTA-BP-H133). US Government Printing Office, Washington, D.C.

  • Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 157:179–184

    CAS  PubMed  Google Scholar 

  • Weissman M, Jensen P (2000) What research suggests for depressed women with children. Paper presented for the Treatment and Prevention/Targeted Population Section of the Summit on Women and Depression, Queenstown, Md.

  • Weissman MM, Warner V, Wickramaratne P, Moreau D, Olfson M (2001) Offspring at risk: early onset major depression and anxiety disorders over a decade. In: Rapoport JL (ed) Childhood onset of "adult" psychopathology: clinical and research advances. American Psychopathological Association Series, Washington, D.C., pp 245–258

  • Wendler D (2000) Informed consent, exploitation and whether it is possible to conduct human subjects research without either one. Bioethics 14:310–339

    CAS  PubMed  Google Scholar 

  • Wisner KL, Perel JM (1988) Psychopharmacologic agents and electroconvulsive therapy during pregnancy and the puerperium. In: Cohen RL (ed) Psychiatric consultation in childbirth settings: parent- and child-oriented approaches. Plenum, New York, pp 165–206

  • Wisner KL, Perel JM, Peindl KS, Gracious BL (2000) Depression during pregnancy and the postpartum period. Paper presented for the Treatment and Prevention/Targeted Population Section of the Summit on Women and Depression. Queenstown, Md.

Download references

Acknowledgements

This research was supported, in part, by National Institute of Mental Health grants MH29618 (Dr. Frank), MH30915 (Drs. Kupfer and Frank). The first author also acknowledges the multiple contributions to this report that arose from discussions with Drs. Charles Nemeroff, A. John Rush, Robert Levine, Laura Roberts, Arthur Kaplan, Paul Weaver and Mr. James McNulty, all members of the NIMH Human Subjects Research Council Workgroup and Dr. David Shore who staffed the Workgroup.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ellen Frank.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frank, E., Novick, D.M. & Kupfer, D.J. Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies. Psychopharmacology 171, 19–26 (2003). https://doi.org/10.1007/s00213-003-1477-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1477-z

Keywords

Navigation